GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Furiex Pharmaceuticals, Inc. (FURX) [hlAlert]

Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company?s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and
PPD 10558. Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.
( Total: 3 Current Stock Recommendations )
Furiex Pharmaceuticals, Inc.   (3)
Buy 100%
Related companies
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
TONGITANG CHINESE ...   (2)
Hold 100%
Achillion ...   (15)
Sell Hold 27% Buy 67%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Show  

Date (ET)MemberRatingYTD
Gains
 
1/28/2013  
Buy
  
10/21/2011  
Buy
  
2/4/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy